Take Action

Reports

Filter By:
DSH Hospitals’ 340B Profit Often Exceeds Charity Care Spending
March 27, 2024
Charity Care at 340B Hospitals is on a Downward Trend
October 1, 2023
340B – A missed opportunity to address those that are medically underserved
July 4, 2023
What’s in a Name? Rural Referral Centers Capture 340B Discounts Without Serving Rural, Vulnerable Patients
July 1, 2023
Fulfilling a Social Responsibility: Comparing 340B and Non-340B Hospitals’ Contributions to Their Communities
October 24, 2022
340B Hospitals Continue to Provide Below Average Rates of Charity Care
February 1, 2022
340B – A missed opportunity to address those that are medically underserved
November 18, 2021
Access to the 340B Drug Pricing Program: is there evidence of strategic hospital behavior? 
June 3, 2021
340B Drug Pricing Program: Analysis Reveals $40 Billion in Profits in 2019
May 1, 2021
The Impact of Growth in 340B Contract Pharmacy Arrangements – Six Years Later
October 1, 2020
Measuring the Relative Size of the 340B Program: 2018 Update
June 1, 2020
Public Opinion Poll on 340B Drug Pricing Program
March 1, 2020
Charity Care Provision by US Nonprofit Hospitals
February 17, 2020
GAO Report: Increased Oversight Needed to Ensure Nongovernmental Hospitals Meet Eligibility Requirements
January 1, 2020
GAO Report: Oversight of the Intersection with the Medicaid Drug Rebate Program Needs Improvement
January 1, 2020
Left Behind: An Analysis of Charity Care Provided by Hospitals Enrolled in the 340B Discount Program
November 1, 2019
GAO Report: Characteristics of Hospitals Participating and Not Participating in the 340B Program
July 18, 2018
Measuring the Relative Size of the 340B Program: 2017 Update
July 1, 2018
GAO Report: Federal Oversight of Compliance at 340B Contract Pharmacies Needs Improvement
June 28, 2018
340B Hospitals Continue to Expand: Growth and Distribution of Physician-Administered Drug Reimbursement Across Ten Therapeutic Areas
May 1, 2018
New Analysis Provides Evidence of Hospitals not Using the 340B Program as Intended
October 1, 2017
GAO Report: Update on Agency Efforts to Improve 340B Program Oversight
July 18, 2017
Measuring the Relative Size of the 340B Program: 2012–2017
July 1, 2017
COA: The 340B Drug Discount Program in Review: A Look at the Data and Evidence to Date
April 1, 2017
340B Program Sales Forecast: 2016-2021
December 1, 2016
Benefiting Hospitals, Not Patients: An Analysis of Charity Care Provided by Hospitals Enrolled in the 340B Discount Program
May 1, 2016
Compliance Trends with Hospital Charity Care Requirements
April 25, 2016
Fact Sheet on Distribution of Physician Administered Drugs in 340B
February 2, 2016
Hospital Acquisitions of Physician Practices and the 340B Program
June 8, 2015
GAO Report: Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals
June 1, 2015
GAO Report Summary
February 2, 2015
Primer: Understanding the 340B Drug Pricing Program
June 4, 2014
Impact on Medicare Payments of Shift in Site of Care for Chemotherapy Administration
June 1, 2014
Innovations in Cancer Care and Implications for Health Systems
May 1, 2014
340B Covered Entity Acquisitions of Physician-based Oncology Practices
April 22, 2014
Unfulfilled Expectations: An Analysis of Charity Care Provided in 340B Hospitals
April 4, 2014
The Impact of Growth in 340B Contract Pharmacy Arrangements
January 1, 2014
Unprecedented Growth, Questionable Policy: The 340B Drug Program
January 1, 2014
Results of Analyses for Chemotherapy Administration Utilization and Chemotherapy Drug Utilization, 2005-2011 for Medicare Fee for-Service Beneficiaries
May 29, 2013
GAO Report: Manufacturer Discounts in the 340B Program Offer Benefits, But Federal Oversight Needs Improvement
September 1, 2011